Literature DB >> 27631746

Trends in HIV Infection Among Persons Who Inject Drugs: United States and Puerto Rico, 2008-2013.

Andrew John Mitsch1, H Irene Hall1, Aruna Surendera Babu1.   

Abstract

OBJECTIVES: To describe trends in HIV diagnoses and prevalence among persons who inject drugs (PWID), and trend variations by jurisdiction.
METHODS: We used National HIV Surveillance System data to estimate the number of HIV diagnoses made during 2008 through 2013, and measured trends by estimated annual percent change; and persons living with diagnosed HIV infection at year-end 2008 to 2012, and measured trends in prevalence by the 2012-2008 arithmetic difference.
RESULTS: During 2008 through 2013, the number of HIV diagnoses was stable among all persons (< 2% per year), and decreased among PWID (> 10% per year) overall and in 10 jurisdictions. The Black-to-White PWID diagnosis ratio was 2 to 1. During 2008 through 2012, the number of persons living with diagnosed HIV infection increased overall, was stable among PWID, and decreased in 14 jurisdictions.
CONCLUSIONS: Had the rate of decrease in diagnoses of HIV infection among PWID equaled that of all persons, an additional 1500 diagnoses would have occurred between 2008 and 2013. Prevalence was stable among PWID, and increased overall among all persons living with HIV infection. Pronounced racial inequities persist, particularly for Blacks, and appear to be diminishing.

Entities:  

Mesh:

Year:  2016        PMID: 27631746      PMCID: PMC5104990          DOI: 10.2105/AJPH.2016.303380

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  28 in total

1.  Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes.

Authors:  Julio S G Montaner; Evan Wood; Thomas Kerr; Viviane Lima; Rolando Barrios; Kate Shannon; Richard Harrigan; Robert Hogg
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

2.  Pneumocystis pneumonia--Los Angeles.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1981-06-05       Impact factor: 17.586

3.  Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?

Authors:  David C Perlman; Don C Des Jarlais; Jonathan Feelemyer
Journal:  J Addict Dis       Date:  2015

4.  Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for "Ending the Epidemic".

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Jonathan Feelemyer; Holly Hagan; Hannah L F Cooper; Aimee N C Campbell; Susan Tross; David C Perlman
Journal:  AIDS Behav       Date:  2016-02

5.  Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach.

Authors:  Kathleen McDavid Harrison; Tebitha Kajese; H Irene Hall; Ruiguang Song
Journal:  Public Health Rep       Date:  2008 Sep-Oct       Impact factor: 2.792

6.  Consistent Estimates of Very Low HIV Incidence Among People Who Inject Drugs: New York City, 2005-2014.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Jonathan Feelemyer; Aimée N C Campbell; Susan Tross; Lou Smith; Hannah L F Cooper; Holly Hagan; David Perlman
Journal:  Am J Public Health       Date:  2016-01-21       Impact factor: 9.308

7.  Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2012-11-09

8.  HIV infection and HIV-associated behaviors among persons who inject drugs--20 cities, United States, 2012.

Authors:  Michael W Spiller; Dita Broz; Cyprian Wejnert; Lina Nerlander; Gabriela Paz-Bailey
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-03-20       Impact factor: 17.586

9.  Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015.

Authors:  Caitlin Conrad; Heather M Bradley; Dita Broz; Swamy Buddha; Erika L Chapman; Romeo R Galang; Daniel Hillman; John Hon; Karen W Hoover; Monita R Patel; Andrea Perez; Philip J Peters; Pam Pontones; Jeremy C Roseberry; Michelle Sandoval; Jessica Shields; Jennifer Walthall; Dorothy Waterhouse; Paul J Weidle; Hsiu Wu; Joan M Duwve
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-01       Impact factor: 17.586

10.  Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.

Authors:  Hasina Samji; Angela Cescon; Robert S Hogg; Sharada P Modur; Keri N Althoff; Kate Buchacz; Ann N Burchell; Mardge Cohen; Kelly A Gebo; M John Gill; Amy Justice; Gregory Kirk; Marina B Klein; P Todd Korthuis; Jeff Martin; Sonia Napravnik; Sean B Rourke; Timothy R Sterling; Michael J Silverberg; Stephen Deeks; Lisa P Jacobson; Ronald J Bosch; Mari M Kitahata; James J Goedert; Richard Moore; Stephen J Gange
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

View more
  7 in total

1.  Mortgage Discrimination and Racial/Ethnic Concentration Are Associated with Same-Race/Ethnicity Partnering among People Who Inject Drugs in 19 US Cities.

Authors:  Sabriya L Linton; Hannah L F Cooper; Yen-Tyng Chen; Mohammed A Khan; Mary E Wolfe; Zev Ross; Don C Des Jarlais; Samuel R Friedman; Barbara Tempalski; Dita Broz; Salaam Semaan; Cyprian Wejnert; Gabriela Paz-Bailey
Journal:  J Urban Health       Date:  2020-02       Impact factor: 3.671

2.  Racial Inequities in HIV Prevalence and Composition of Risk Networks Among People Who Inject Drugs in HIV Prevention Trial Network 037.

Authors:  Florence Momplaisir; Mustafa Hussein; Danielle Tobin-Fiore; Laramie Smith; David Bennett; Carl Latkin; David S Metzger
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-01       Impact factor: 3.731

3.  HIV Prevalence and Related Behaviors Among People Who Inject Drugs in Iran from 2010 to 2020.

Authors:  Mohammad Karamouzian; Hamid Sharifi; Mehrdad Khezri; Mostafa Shokoohi; Ali Mirzazadeh; Fatemeh Tavakoli; Nima Ghalekhani; Ghazal Mousavian; Soheil Mehmandoost; Parvin Afsar Kazerooni; Ali Akbar Haghdoost
Journal:  AIDS Behav       Date:  2022-02-23

4.  Use of Injection Drugs and Any Form of Methamphetamine in the Portland, OR Metro Area as a Driver of an HIV Time-Space Cluster: Clackamas, Multnomah, and Washington Counties, 2018-2020.

Authors:  Jaime Walters; Lea Busy; Christopher Hamel; Kelsi Junge; Timothy Menza; Jaxon Mitchell; Taylor Pinsent; Kim Toevs; Jennifer Vines
Journal:  AIDS Behav       Date:  2021-11-10

5.  Application of machine learning algorithms for localized syringe services program policy implementation - Florida, 2017.

Authors:  Tyler S Bartholomew; Hansel E Tookes; Emma C Spencer; Daniel J Feaster
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

6.  Employing Respondent Driven Sampling (RDS) to recruit people who inject drugs (PWID) and other hard-to-reach populations during COVID-19: Lessons learned.

Authors:  Roberto Abadie; Patrick Habecker; Kimberly Gocchi Carrasco; Kathy S Chiou; Samodha Fernando; Sydney J Bennett; Aníbal Valentin-Acevedo; Kirk Dombrowski; John T West; Charles Wood
Journal:  Front Psychiatry       Date:  2022-10-03       Impact factor: 5.435

7.  Prevalence and risk factors associated with HIV-1 infection among people who inject drugs in Dar es Salaam, Tanzania: a sign of successful intervention?

Authors:  Samuel Lazarus Likindikoki; Elia John Mmbaga; Germana Henry Leyna; Kåre Moen; Neema Makyao; Mucho Mizinduko; Alex Ishungisa Mwijage; Diana Faini; Melkizedeck Thomas Leshabari; Dan Wolf Meyrowitsch
Journal:  Harm Reduct J       Date:  2020-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.